I had accidentally posted this onto another thread, so moving the comment here.
In typical Dr Charles "Snuffy" Myers fashion, inhis weekly video he has a gut feel that eraly Taxotere while effective is no more effective than early Xtandi or early Zytiga would be, just have not had enough randomized control trials to prove his hypothesis.
/askdrmyers.wordpress.com/TallAllen commented on that comment I had misplaced in the other thread ...
"Lupron Jim -
If you're talking about
the CHAARTED study, it was a randomized controlled trial. Some were randomized to receive Taxotere+ADT, while others got ADT alone. Since Xtandi and Zytiga are alternate forms of ADT, they would not substitute for Taxotere, which attacks the cancer in an entirely different way than any kind of ADT.
A recent Phase II trial of Xtandi monotherapy in hormone-naive men demonstrated good efficacy in men with or without mets. There is a randomized controlled trial of Zytiga+ADT in hormone-naive metastatic men in the works. Since traditional ADT, Zytiga and Xtandi all target the androgen receptor in different ways, they could all potentially be used in a cocktail if they are safe and retain efficacy when used that way....
- Allen"
LupronJim